On September 7, 2022 Celsion Corporation (NASDAQ: CLSN), a clinical-stage drug development company reported that Dr. Corinne Le Goff, President and Chief Executive Officer will present a company overview and be available for 1×1 meetings at the upcoming H.C. Wainwright 24th Annual Global Investment Conference (Press release, Celsion, SEP 7, 2022, View Source [SID1234619138]). The hybrid conference will be held from September 12-14 with in-person participation held at the Lotte New York Palace Hotel.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Dr. Le Goff will present in person on Tuesday, September 13th at 4:00 pm ET. A replay of the presentation will available under "Financial Events" in the Investors section of the Company’s website at: View Source